Updates

Ellele Health has launched Ellele-02, a multi-site exploratory study aimed at advancing the early detection of gynaecological cancers. The study is being conducted across two NHS sites: the Royal Infirmary of Edinburgh and Queen Elizabeth Hospital, Gateshead. Continue reading…

OriCol™ has also been featured in The Sun, highlighting the potential of our 90-second triomic test to dramatically reduce the need for invasive colonoscopies across the NHS. Continue reading…

Today marks a major milestone for Origin Sciences with the publication of our latest research in Nature Communications: “Hologenomic analysis of rectal mucus sampling for detection of adenomatous polyps and colorectal cancer.” Continue reading…

Origin is proud to see The Times highlight the potential of OriCol™, our 90-second triomic test designed to transform bowel cancer assessment and reduce reliance on invasive colonoscopies. The article underscores OriCol™’s ability to spare more than 600,000 people each year from unnecessary procedures. Continue reading…

Ellele Health was proud to be selected as a start-up case study for the EnterpriseTECH programme at Cambridge Judge Business School, a transformative 10-week initiative designed to help researchers deepen their understanding of entrepreneurship and the process of taking early-stage technology to market. Continue reading…

Origin Sciences is pleased to announce that OriCol™, the innovative sampling device manufactured by TOGL, has successfully achieved CE marking under the European Union Medical Device Regulation (MDR 2017/745). Continue reading…